With facilities in both Montreal, Quebec, and Fargo, North Dakota, Algorithme Pharma is an established full service provider focused on early stage clinical research. With access to an extensive database of healthy, patient and special populations, Algorithme Pharma's comprehensive full service Phase I/IIa offering provides sponsors with high quality trial conduct, Therapeutic class expertise, as well as accelerated study-start and report timelines.

Click here to download the Data Sheet »

Algorithme Pharma's Experience

  • Over 50 early stage trials involving anti-diabetic and hypoglycemic agents
  • 75 Type I and Type II diabetes patients enrolled over four weeks, in a single-center trial
  • Pharmacodynamics and Immunogenicity assessment
  • High-Glycemic Load Challenge/Tolerance Test
  • Insulin-Induced Hypoglycemic Event in Type 1 Diabetes - assessment of potential rescue medications

Patient Access

  • 750+ Type l diabetics
  • 1500+ Type II diabetics, on:
    • Metformin only: 500+
    • Metformin + other oral hypoglycemic agent: 650+
    • Insulin: 300+
  • Access to referring physicians and industry experts
  • Searchable database to qualify IE criteria for pre-existing conditions, demographics, medication use and BMI

Clinical Expertise

  • Vast experience with FIH, adaptive designs, 505(b)(2), and PK assessments involving healthy subjects and patient arms
  • Setup for medical, scientific, regulatory and operational procedures
  • Support services, including customized protocol design, data management, bioanalysis, biostats and reporting
  • Administration of medication via multiple routes — including parenteral, intranasal, intramuscular and subcutaneous, etc.